AJP - Renal Physiology, Vol 261, Issue 3 488-F494, Copyright © 1991 by American Physiological Society

ARTICLES

Thromboxane stimulates synthesis of extracellular matrix proteins in vitro

L. A. Bruggeman, E. A. Horigan, S. Horikoshi, P. E. Ray and P. E. Klotman
Molecular Medicine Section, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20892.

The vasoconstrictor eicosanoid thromboxane plays an important role in the pathogenesis of several renal diseases. As an autacoid, its local release alters blood flow and induces platelet aggregation. We report a direct stimulatory effect of thromboxane on extracellular matrix protein production and gene expression in vitro. Treatment of two cell types, differentiated mouse teratocarcinoma cells (F9+) and human glomerular mesangial cells, with two different thromboxane analogues resulted in increased production of components of the extracellular matrix including fibronectin and the basement membrane proteins laminin and type IV collagen. These responses to thromboxane were not the result of a mitogenic effect of thromboxane nor the result of an increase in total cellular protein. The increased production of extracellular matrix proteins was, at least in part, due to an increase in the steady-state level of mRNA for these genes. Furthermore, the effect of thromboxane was markedly inhibited by cotreatment with a thromboxane-receptor antagonist. These results suggest a new potential role for thromboxane as a mediator of the sclerotic and fibrotic responses to injury.

This article has been cited by other articles:

				M. M. Sellers and J. N. Stallone Sympathy for the devil: the role of thromboxane in the regulation of vascular tone and blood pressure Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H1978 - H1986. [Abstract] [Full Text] [PDF]

				A. R. R. Goncalves, C. K. Fujihara, A. L. Mattar, D. M. A. C. Malheiros, I. L. Noronha, G. de Nucci, and R. Zatz Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory Am J Physiol Renal Physiol, May 1, 2004; 286(5): F945 - F954. [Abstract] [Full Text] [PDF]

				T. J. Weber, T. J. Monks, and S. S. Lau DDM-PGE2-mediated cytoprotection in renal epithelial cells by a thromboxane A2 receptor coupled to NF-kappa B Am J Physiol Renal Physiol, February 1, 2000; 278(2): F270 - F278. [Abstract] [Full Text] [PDF]

				T. M. Coffman, R. F. Spurney, R. B. Mannon, and R. Levenson Thromboxane A2 modulates the fibrinolytic system in glomerular mesangial cells Am J Physiol Renal Physiol, August 1, 1998; 275(2): F262 - F269. [Abstract] [Full Text] [PDF]

				C. K. Fujihara, D. M. A. C. Malheiros, J. L. Donato, A. Poli, G. De Nucci, and R. Zatz Nitroflurbiprofen, a new nonsteroidal anti-inflammatory, ameliorates structural injury in the remnant kidney Am J Physiol Renal Physiol, March 1, 1998; 274(3): F573 - F579. [Abstract] [Full Text] [PDF]